• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: TOSOH CORPORATION G8

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

TOSOH CORPORATION G8 Back to Search Results
Model Number G8
Device Problem Incorrect, Inadequate or Imprecise Result or Readings (1535)
Patient Problem No Known Impact Or Consequence To Patient (2692)
Event Date 11/05/2019
Event Type  malfunction  
Manufacturer Narrative
Fse arrived at the site to address the reported event.Fse was unable to reproduce the failure of these samples, however, by running a replicate of each fse observed that all the samples of the cap survey were on the edge of the upper limit and that qc results were within acceptable range and close to median for lot 7090.Further inspection of the device revealed that the small syringe was crusted and dirty at the base and that it was bubbling and leaking every time the syringe would move.Fse replaced the small syringe to resolve the issue.Fse was subsequently able to validate the instrument using calibration lot #zs800 by running calibration; qc, cap samples, and patient samples.No further issues were noted.No further action was required by field service.A 13-month complaint service history review for similar complaints was performed for serial number (b)(4) from 05oct2018 through aware date 05nov2019.There were no similar complaints identified during the review period.The st hba1c aia-pack package insert states the following: quality control: in order to monitor and evaluate the precision of the analytical performance, it is recommended that commercially available control samples be assayed daily.The minimum recommendations for the frequency of running internal control material are: after calibration, three levels of controls are run in order to accept the calibration curve.The three levels of controls are also repeated after calibration when certain service procedures are performed (e.G.Temperature adjustment, sampling mechanism changes, maintenance of the wash probe or detector lamp adjustment or change).After daily maintenance, at least two levels of the control should be run in order to verify the overall performance of the tosoh aia system analyzers.If one or more control sample value(s) is out of the acceptable range, it will be necessary to investigate the validity of the calibration curve and the assay results before reporting patient values.Standard laboratory procedures should be followed in accordance with the regulatory agency under which the laboratory operates.Limitations of the procedure for diagnostic purposes, the results obtained from this assay should be used in conjunction with other data (e.G., symptoms, results of other tests, clinical impressions, therapy, etc.).The most probable cause of the reported event was due to a worn, leaking small syringe.
 
Event Description
The customer reported receiving a failed college of american pathologists (cap) survey using tosoh quality control (qc) material, lot# 7076, on their g8 analyzer.The cap survey hemoglobin a1c (hba1c) samples and qc results were reported to be outside of the acceptable range by 0.1%.The customer stated they noticed high bias since the last periodic maintenance (pm) had been performed.The column count was noted to be 2186 injections and sa1crt was 0.60 ml/ min.The reported high bias occurred with multiple columns and calibrations.The customer stated they were using calibration lot # zs-8001.Technical support (ts) instructed the customer to recalibrate with calibration lot # zs-8002, run qc and call back with the results.The customer called back and reported that they installed a new column and recalibrated with the new calibration lot.Both of the qc results were in range per the target ranges, but the upward shift remained.The customer requested service.A field service engineer (fse) was dispatched to address the reported event.There was no indication of any patient intervention or adverse health consequences due to the reported event.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
G8
Type of Device
G8
Manufacturer (Section D)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, 10586 23
JA  1058623
Manufacturer (Section G)
TOSOH CORPORATION
shiba-koen first building
3-8-2 shiba
minato-ku, 10586 23
JA   1058623
Manufacturer Contact
bernadette oconnell
shiba-koen first building
3-8-2 shiba
minato-ku, tokyo 10586-23
JA   1058623
MDR Report Key9724183
MDR Text Key205687293
Report Number8031673-2019-00559
Device Sequence Number1
Product Code LCP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
K131580
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional
Reporter Occupation Other
Type of Report Initial
Report Date 02/18/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received02/18/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Model NumberG8
Device Catalogue Number021560
Was Device Available for Evaluation? Yes
Date Manufacturer Received11/05/2019
Was Device Evaluated by Manufacturer? Yes
Date Device Manufactured03/01/2011
Is the Device Single Use? No
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Reuse
Patient Sequence Number1
-
-